Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Receivables: 2021-2024

Historic Receivables for Roivant Sciences (ROIV) over the last 4 years, with Dec 2024 value amounting to $678,000.

  • Roivant Sciences' Receivables fell 98.35% to $678,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $86.4 million, marking a year-over-year decrease of 46.23%. This contributed to the annual value of $678,000 for FY2024, which is 98.35% down from last year.
  • As of FY2024, Roivant Sciences' Receivables stood at $678,000, which was down 83.01% from $4.0 million recorded in FY2024.
  • Roivant Sciences' 5-year Receivables high stood at $41.1 million for FY2023, and its period low was -$88.8 million during FY2021.
  • For the 3-year period, Roivant Sciences' Receivables averaged around $18.0 million, with its median value being $16.0 million (2022).
  • As far as peak fluctuations go, Roivant Sciences' Receivables surged by 683.37% in 2023, and later tumbled by 98.35% in 2024.
  • Roivant Sciences' Receivables (Yearly) stood at -$88.8 million in 2021, then reached $8.9 million in 2021, then surged by 104.37% to $3.9 million in 2022, then spiked by 213.50% to $28.0 million in 2022, then surged by 683.37% to $30.4 million in 2023, then surged by 46.88% to $41.1 million in 2023, then plummeted by 86.87% to $4.0 million in 2024, then slumped by 98.35% to $678,000 in 2024.